MYZOMIB 2MG INJECTION Substitute

MYZOMIB 2MG INJECTION contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells.

MYZOMIB 2MG INJECTION is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection into your vein (intravenously or IV) or under your skin (subcutaneously, or SC). MYZOMIB 2MG INJECTION must not be administered into your spinal fluid (intrathecally).

Yes, MYZOMIB 2MG INJECTION can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or believe you have an infection.

Avoid taking MYZOMIB 2MG INJECTION if you are pregnant because MYZOMIB 2MG INJECTION can cause harmful effects on the unborn baby. Females should follow effective birth control methods during treatment and at least six months after the final dose of MYZOMIB 2MG INJECTION.

Before you receive treatment with MYZOMIB 2MG INJECTION, tell your doctor about all of your medical conditions. You should not receive MYZOMIB 2MG INJECTION if you are allergic to bortezomib or any contents in MYZOMIB 2MG INJECTION.